Evidence map›Paper›PMID 29418020›Full record

ArticleMolecular microbiology2018

What is Vipp1 good for?

Benedikt Junglas, Dirk Schneider

Abstract readComment
PubMed Publisher
In one paragraph

Article in Molecular microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Benedikt JunglasInstitut für Pharmazie und Biochemie, Johannes Gutenberg-Universität Mainz, Mainz, Germany.
Dirk SchneiderInstitut für Pharmazie und Biochemie, Johannes Gutenberg-Universität Mainz, Mainz, Germany.ORCID 0000-0003-4517-6387

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While Vipp1 (also known as IM30) clearly is essential for proper biogenesis of thylakoid membranes in chloroplasts and cyanobacteria, the exact function of Vipp1/IM30 still remains unclear. The recent in vivo study of Gutu et al. now demonstrates that Vipp1/IM30 forms localized puncta specifically at highly curved membrane regions at the cell periphery. These Vipp1/IM30 puncta were found being highly dynamic under normal growth conditions, while it has recently been shown that they stably associate with membranes under high-light conditions. These observations, together with the observation that other Vipp1/IM30 homologous proteins also form puncta under stress conditions, indicate a protective function of these proteins at stressed membrane regions. However, Gutu et al. additionally show that Vipp1/IM30 is of special importance when growing cells are shifted from dark to light growth conditions, which could be explained by light stress, by thylakoid membrane dynamics and/or by photosystem biogenesis, which is being discussed in this article.

Indexed as

Carrier ProteinsThylakoidsChloroplastsMembrane ProteinsPhotosynthesisCarrier ProteinsMembrane Proteins

Identifiers

PMID29418020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.